City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Jana Portnow, MD  
Search results:  6  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-6 Trials Jump to page:

COH Protocol Number: 13418 ClinicalTrials.gov Number: NCT02014844

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  An Open-Label Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of Aldoxorubicin in Subjects with Unresectable Glioblastoma Whose Tumors Have Progressed Following Prior Treatment with Surgery, Radiation and Temozolomide

COH Protocol Number: 13123 ClinicalTrials.gov Number: NCT00916409

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Prospective, Multi-Center Trial of NovoTTF-100A Together with Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

COH Protocol Number: 13116 ClinicalTrials.gov Number: NCT01156584

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Phase I Ascending Dose Trial of the Safety and Tolerability of Toca 511 in Patients with Recurrent High Grade Glioma

COH Protocol Number: 12242

Principal Investigator: Jana Portnow, MD
Sponsor: Institutional

Title:  An Intracerebral Microdialysis Study in Patients with Recurrent High Grade Gliomas Being Treated with TOCA 511 and TOCA FC

COH Protocol Number: 11216 ClinicalTrials.gov Number: NCT01480479

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The "ACT IV" Study)

COH Protocol Number: 11180 ClinicalTrials.gov Number: NCT00045968

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Phase III Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

 
Results per page: 25 50 100 All 1-6 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.